Chirana T. Injecta, a.s. has acquired Chirmax, s.r.o.
Chirana T. Injecta, a.s. has acquired a 100% stake in Chirmax, s.r.o., the Czech manufacturer of surgical suture material, for an undisclosed consideration.
Chirana T. Injecta, a.s. is a manufacturer of disposable medical devices.
Oaklins' team in the Czech Republic acted as financial advisor to the buyer in this transaction.
Talk to the deal team
Related deals
Therapy Equipment has been acquired by ESAB Corporation
Owner Venture Managers has sold Therapy Equipment Ltd. to ESAB Corporation.
Learn moreMBI Healthcare Technologies has been acquired by DNV AS
The founders of MBI Healthcare Technologies have sold the company to DNV AS. The acquisition forms part of DNV’s strategic expansion into the digital health market, where it aims to significantly grow its presence through innovation, acquisitions, and partnerships. DNV and MBI will work to rapidly scale MBI’s solutions in the UK, target growth in international markets and bring new data assurance technologies to the healthcare sector.
Learn moreSulAmérica and Rede D’Or São Luiz have announced a combination
SulAmérica (B3:SULA11), a leading insurance company in Brazil, has announced a combination with Rede D’Or São Luiz S.A. (B3:RDOR3), the largest Brazilian hospital network. The companies had a combined market value of approximately US$21 billion on 18 February 2022.
Learn more